Showing results (941-950 of 1,878) with videos related to
Sort By:
Pageof 188
Immunotherapy|February 21, 2012
Novel routes for allergen immunotherapy: safety, efficacy and mode of actionPhilippe Moingeon, Laurent MascarellImmunotherapy|February 21, 2022
A global picture: therapeutic perspectives for COVID-19Vivek P Chavda, Carron Kapadia, Shailvi Soni, et al.Immunotherapy|February 21, 2022
Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinomaLong Long, Li Zhang, Yuhan Yang, et al.Immunotherapy|September 24, 2021
Immunoregulatory T cell epitope peptides for the treatment of allergic diseaseRashi Ramchandani, Lubnaa Hossenbaccus, Anne K EllisImmunotherapy|October 7, 2021
Safety and effectiveness of the 300 IR sublingual house dust mite allergen immunotherapy tablet: 2-year interim analysis of a specified drug-use surveyYoshitaka Okamoto, Kiyonori Ishii, Moe Kato, et al.Immunotherapy|June 22, 2019
CD73: an emerging checkpoint for cancer immunotherapySiqi Chen, Derek A Wainwright, Jennifer D Wu, et al.Immunotherapy|October 25, 2021
Hurdles for the wide implementation of photoimmunotherapyKohei Matsuoka, Mitsuo Sato, Kazuhide SatoImmunotherapy|February 14, 2022
miRNA profiles change during grass pollen immunotherapy irrespective of clinical outcomeKrzysztof Specjalski, Agnieszka Maciejewska, Jan Romantowski, et al.Immunotherapy|October 10, 2019
Manufacturing process optimization of ADMA Biologics' intravenous immunoglobulin products, BIVIGAM® and ASCENIV™Richard L Wasserman, Daniel Garcia, Benjamin N Greener, et al.Immunotherapy|April 25, 2022
Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitisAntonio Valero, Ethel Ibáñez-Echevarría, Carmen Vidal, et al.Pageof 188